LANL数据库分析:HIV-1各亚型中与temsavir敏感性降低相关的gp160多态性流行率
该研究查询洛斯阿拉莫斯国家实验室HIV序列数据库中7560条全长gp160序列,分析已知降低temsavir敏感性的氨基酸多态性(S375、M426、M434、M475)的流行率。总体而言,这些多态性在所有序列和多数常见亚型中流行率较低,但在CRF01_AE和01B中S375H和M475I占主导。
要点
- 在全部7560条序列中,与temsavir敏感性降低相关的特定多态性总体流行率低于10%。
- CRF01_AE中S375H占99.3%、M475I占76.3%,与既往报道的该重组型temsavir敏感性低一致。
- CRF01B中S375H占71.7%、M475I占49.5%,提示需关注这些亚型的耐药风险。
核心结论
- 在LANL HIV序列数据库中,具有降低temsavir敏感性潜力的gp160氨基酸多态性总体流行率低,且在多数常见亚型中也低。
- CRF01_AE和CRF01B中S375H和M475I多态性占主导,与这些亚型已知的低temsavir敏感性相符。
研究设计与样本
- 基于洛斯阿拉莫斯国家实验室HIV序列数据库的回顾性序列分析。
- 查询了7560条全长gp160序列,以B亚型共识序列为参照,报告所有序列及亚型(数据库内≥10条分离株)的氨基酸多态性频率。
主要发现
- 数据库中239个亚型中,5个最常见亚型为B(n=2651,35.1%)、C(n=1626,21.5%)、CRF01_AE(n=674,8.9%)、A1(n=273,3.6%)和CRF02_AG(n=199,2.6%)。
- 在所有7560条序列中,关注位点(S375、M426、M434、M475)最流行的氨基酸与B亚型共识相同,分别为73.5%、82.1%、88.2%、89.9%。
- 具有降低temsavir敏感性潜力的特定多态性(S375H/I/M/N/T/Y、M426L/P、M434I/K、M475I)在D、G、A6、BC、F1、CRF07_BC、CRF08_BC、02A、CRF06_cpx、F2、02G和02B亚型中<10%。
- CRF01_AE中S375H占99.3%、M475I占76.3%;CRF01B中S375H占71.7%、M475I占49.5%。
关键数值与推荐
- 重点关注位点为gp160氨基酸位置S375、M426、M434和M475。
- 与temsavir敏感性降低相关的特定多态性包括S375H/I/M/N/T/Y、M426L/P、M434I/K和M475I。
- 频率报告限于数据库中有≥10条分离株的亚型/循环重组型。
临床怎么用
- 对于拟使用fostemsavir的重度治疗经治HIV-1感染者,应考虑其病毒亚型及gp160耐药相关多态性。
- CRF01_AE和CRF01B感染者中S375H和M475I高流行,提示可能天然对temsavir敏感性降低。
- 大多数常见亚型中这些多态性流行率低,支持fostemsavir在相应人群中的潜在应用。
局限性
- 数据库序列可能存在选择偏倚,不能完全代表临床人群。
- 未报告多态性与表型敏感性直接关联的功能数据。
- 未提供各亚型内多态性频率的置信区间或统计比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fostemsavir, a prodrug of the gp120-directed attachment inhibitor temsavir, is indicated for use in heavily treatment-experienced individuals with MDR HIV-1. Reduced susceptibility to temsavir in the clinic maps to discrete changes at amino acid positions in gp160: S375, M426, M434 and M475. OBJECTIVES: To query the Los Alamos National Laboratory (LANL) HIV Sequence Database for the prevalence of polymorphisms at gp160 positions of interest. METHODS: Full-length gp160 sequences (N = 7560) were queried for amino acid polymorphisms relative to the subtype B consensus at positions of interest; frequencies were reported for all sequences and among subtypes/circulating recombinant forms (CRFs) with ≥10 isolates in the database. RESULTS: Among 239 subtypes in the database, the 5 most prevalent were B (n = 2651, 35.1%), C (n = 1626, 21.5%), CRF01_AE (n = 674, 8.9%), A1 (n = 273, 3.6%) and CRF02_AG (n = 199, 2.6%). Among all 7560 sequences, the most prevalent amino acids at positions of interest (S375, 73.5%; M426, 82.1%; M434, 88.2%; M475, 89.9%) were the same as the subtype B consensus. Specific polymorphisms with the potential to decrease temsavir susceptibility (S375H/I/M/N/T/Y, M426L/P, M434I/K and M475I) were found in <10% of isolates of subtypes D, G, A6, BC, F1, CRF07_BC, CRF08_BC, 02A, CRF06_cpx, F2, 02G and 02B. S375H and M475I were predominant among CRF01_AE (S375H, 99.3%; M475I, 76.3%; consistent with previously reported low temsavir susceptibility of this CRF) and 01B (S375H, 71.7%; M475I, 49.5%). CONCLUSIONS: Analysis of the LANL HIV Sequence Database found a low prevalence of gp160 amino acid polymorphisms with the potential to reduce temsavir susceptibility overall and among most of the common subtypes.
引用
- Gartland M, Arnoult E, Foley BT, et al. Prevalence of gp160 polymorphisms known to be related to decreased susceptibility to temsavir in different subtypes of HIV-1 in the Los Alamos National Laboratory HIV Sequence Database. J Antimicrob Chemother. 2021. PMID: 34297843. doi:10.1093/jac/dkab257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。